Antonio Antón
Researcher Next ID · RN-043829
Researcher · Biochemistry, Genetics and Molecular Biology
Zaragoza, Mexico
- Works count
- 313
- Citation count
- 5,213
- H-index
- 30
- i10-index
- 60
Research interests
Publications
Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial
The Lancet Oncology · 2020 · https://doi.org/10.1016/s1470-2045(20)30068-1
First-Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single-Agent Bevacizumab as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: The Phase III MACRO TTD Study
The Oncologist · 2012 · https://doi.org/10.1634/theoncologist.2011-0249
Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer
Journal of Clinical Oncology · 2005 · https://doi.org/10.1200/jco.2004.00.1990
Randomized Phase III Study of Gemcitabine-Cisplatin Versus Etoposide-Cisplatin in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung Cancer
Journal of Clinical Oncology · 1999 · https://doi.org/10.1200/jco.1999.17.1.12
Current projects
No projects listed.